Get started
Author

Jeffery M. Holzbeierlein

Observed names: J. Holzbeierlein, J. M. Holzbeierlein, J.M. Holzbeierlein, Jeffery Holzbeierlein
OpenAlex ID: A5111767547
Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor
2018 · Anuj Khandelwal, Caitlin N. Kent, et al. · Nature Communications · 122
PDF
Androgen Stimulates Matrix Metalloproteinase-2 Expression in Human Prostate Cancer
2003 · Xinbo Liao, J. Brantley Thrasher, et al. · Endocrinology · 114
Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo
2010 · Qing Zhu, Jun Yang, et al. · The Prostate · 98
Glycogen Synthase Kinase-3β Activity Is Required for Androgen-Stimulated Gene Expression in Prostate Cancer
2004 · Xinbo Liao, J. Brantley Thrasher, et al. · Endocrinology · 82
Monitoring T-cell responses in a phase II study of AGS-003, an autologous dendritic cell-based therapy in patients with newly diagnosed advanced stage renal cell carcinoma in combination with sunitinib.
2011 · R. A. Figlin, C. A. Nicolette, et al. · Journal of Clinical Oncology · 21
A phase II study testing the safety and activity of AGS-003 as an immunotherapeutic in subjects with newly diagnosed advanced stage renal cell carcinoma (RCC) in combination with sunitinib.
2010 · A. Amin, A. Dudek, et al. · Journal of Clinical Oncology · 21
ITGCN of the Testis, Contralateral Testicular Biopsy and Bilateral Testicular Cancer
2007 · Michael E. Karellas, Ivan Damjanov, et al. · Urologic Clinics of North America · 15
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
2018 · N. Vasdev, H. Zargar, et al. · World Journal of Urology · 9
PDF
The Role of High Dose Interleukin-2 in the Era of Targeted Therapy
2017 · Jessie Gills, William P. Parker, et al. · The Journal of Urology · 3
Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
2014 · N. Vasdev, H. Zargar, et al. · Newcastle University ePrints (Newcastle Univesity) · 2
Right Ureteral Injury After Radiofrequency Ablation for Atrial Fibrillation
2008 · S.M. Hoestje, J.R. Bertsch, et al. · Urology · 2
Corrigendum to “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” [Eur Urol Focus 2021;7:1347–54]
2022 · Maria Carmen Mir, Michele Marchioni, et al. · European Urology Focus · 1
PDF
Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium
2020 · M. Marchioni, M.C. Mir, et al. · European Urology Open Science · 1
Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium
2017 · N. Vasdev, H. Zagar, et al. · European Urology Supplements · 1
Blue light cystoscopy for diagnosis of urothelial bladder cancer: Results from a multicenter registry
2018 · S. Bazargani, Z. Bateni, et al. · European Urology Supplements
650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
2015 · K. Zargar-Shoshtari, H. Zargar, et al. · European Urology Supplements
Updated immunologic and clinical results from a phase 2 study of AGS-003, an autologous dendritic cell based therapy, in patients with newly diagnosed metastatic renal cell carcinoma in combination with sunitinib.
2011 · Robert A. Figlin, Alpesh Amin, et al.
Works count: 17
Citation count: 492
H-index: 8
I10-index: 7
Year
Topic
Type